TRPV1 and colitis: In conclusion, EA at Zusanli (ST36) relieved hyperalgesia induced by colitis via the inhibition of surface neurogenic inflammation and sympathetic sprouting into the DRG, which were mediated by TRPV1/CGRP, ERK, and TLR4 signaling pathway deactivation.